Geplanter Handelsstart von Digihost an der Nasdaq am Montag, dem 15. November

TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. („Digihost“ oder die „Gesellschaft“) (TSXV: DGHI; OTCQB: HSSHD), ein innovatives Unternehmen mit Sitz in Nordamerika, das im Bereich des individuellen Bitcoin-Minings tätig ist, hat heute bekanntgegeben, dass das Unternehmen zur Notierung am Nasdaq-Kapitalmarkt („Nasdaq“) zugelassen wurde. Der Handel an der […] Lire la suite »

McKinsey & Company Launches CustomerOne to Help Marketers Unlock Growth

NEW YORK and LONDON, Nov. 12, 2021 (GLOBE NEWSWIRE) — McKinsey & Company today announced the launch of CustomerOne, a proven approach and comprehensive toolkit designed to help organizations accelerate personalization and customer value management. CustomerOne draws on advanced analytics, ready-to-use assets and tools, and agile principles to optimize each […] Lire la suite »

Positive Phase 2b results in 2nd line melanoma

Highlight Therapeutics announces positive preliminary results from Phase 2b study of BO-112 + anti-PD1 in confirmed anti-PD1 progressor melanoma patients at SITC Breakthrough cancer treatment shows best-in-class potential to open up 2nd-line immunotherapy market to anti-PD1 resistant patients BO-112 demonstrates potential as best-in-class therapy to overcome anti-PD1 resistance in melanoma […] Lire la suite »

South African Qualification Authority and World Education Services Partner to Facilitate Qualifications Recognition for Refugees and Displaced People in South Africa

OTTAWA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Last night, at the Groningen Declaration Network annual meeting, the South African Qualification Authority (SAQA) and World Education Services (WES) signed a partnership agreement that will ensure eligible refugees and displaced individuals can have their qualifications assessed and recognized in South Africa. A […] Lire la suite »

F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference

Dr. Michelle Morrow to present on F-star’s Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific Poster Presentation of Preclinical Data Demonstrates Potential for F-star’s FS120 First-in-Class OX40/CD137 Tetravalent Dual T Cell Agonist in Combination with Anti-PD-1 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, […] Lire la suite »

Digihost to Commence Trading on Nasdaq on Monday, November 15

TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCQB: HSSHD), an innovative North American-based Bitcoin self-mining company, today announced that the Company has been approved to list on the Nasdaq Capital Market (“Nasdaq”), and that trading on Nasdaq is expected to begin […] Lire la suite »

SOT101 Shows Clinical Benefit in Patients with Advanced Solid Tumors

Majority of patients receiving SOT101 (SO-C101) + pembrolizumab had confirmed clinical benefit Clinical responses have been observed in patients progressing on previous anti-PD-1 treatment SOT101 monotherapy and in combination with pembrolizumab was well tolerated in patients with advanced/metastatic solid tumors BASEL, Switzerland, Nov. 12, 2021 (GLOBE NEWSWIRE) — SOTIO Biotech, […] Lire la suite »

Barrows Hotel Enterprises Focuses on Hotel Improvements

DUBAI, United Arab Emirates, Nov. 12, 2021 (GLOBE NEWSWIRE) — Barrows, the provider of hotel investment and advisory services for hotels in the Middle East and Africa is expanding its professional core activities with Property Improvement Projects and Hotel Improvement Projects As part of the preparations for the scheduled SPAC […] Lire la suite »